Inhibitory Effect of MiR-449b on Cancer Cell Growth and Invasion through LGR4 in Non-Small-Cell Lung Carcinoma

Abstract

Non-small-cell lung carcinoma (NSCLC) is one of the most frequently diagnosed malignancies worldwide. Previous studies have shown that microRNA-449b (miR-449b) functions as a tumor suppressor in many cancers. However, the role of miR-449b in NSCLC is still unknown. In the present study, miR-449b was significantly downregulated in NSCLC samples and cell lines. Bioinformatics analysis revealed that 3′-UTR region of leucine rich repeat containing G protein-coupled receptor 4 (LGR4) mRNA had putative complementary sequences to miR-449b,which was further confirmed by the luciferase assay. Western blotting showed that restoration of miR-449b in NSCLC cells decreased the expression of LGR4. Interestingly, over-expression of miR-449b inhibited growth and invasion of NSCLC cells in vitro. Furthermore, ectopic expression of LGR4 reversed miR-449b-suppressed proliferation and invasion of NSCLC cells. Therefore, the data of the present study demonstrate that miR-449b inhibits tumor cell growth and invasion by targeting LGR4 in NSCLC.

Keywords

non-small-cell lung carcinoma / microRNA-449b / leucine rich repeat containing G protein-coupled receptor 4 / growth / invasion

References

[1] SiegelRL, MillerKD, JemalA. Cancer statistics, 2016.. CA Cancer J Clin, 2016, 66(1): 7-30

[2] RamalingamSS, OwonikokoTK, KhuriFR. Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin, 2011, 61(2): 91-112

[3] SpiraA, EttingerDS. Multidisciplinary management of lung cancer. N Engl J Med, 2004, 350(1): 379-392

[4] ToyokawaG, TakenoyamaM, IchinoseY. Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: a review article. Clin Lung Cancer, 2015, 16(1): 6-14

[5] BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297

[6] HeL, HannonGJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 2004, 5(7): 522-531

[7] JohnB, EnrightAJ, AravinA, et al.. Human MicroRNA targets. PLoS Biol, 2004

[8] Cell, 2009, 136(2):

[9] ChenPS, SuJL, HungMC. Dysregulation of microRNAs in cancer. J Biomed Sei, 2012, 19(1): 90

[10] BoenM, PastorinoU, SozziG. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J, 2012268-274

[11] TangR, YangC, MaX, et al.. MiR-let-7a inhibits cell proliferation, migration, and invasion by downregulating PKM2 in gastric cancer. Oncotarget, 2016, 7(5): 5972-5984

[12] SunXH, GengXL, ZhangJ, et al.. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). Tumour Biol, 2015, 36(3): 2127-2134

[13] DongS, JinM, LiY, et al.. MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. Oncol Rep, 2016, 35(4): 2151-2158

[14] XiangC, CuiSP, KeY. miR-144 inhibited cell proliferation of renal cell carcinoma by targeting MTOR. J Huazhong Univ Sei Technolog Med Sei, 2016, 36(2): 186-192

[15] ChenL, XuL, WangG. Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b. Tumour Biol, 2015, 36: 8653-8660

[16] MortensenMM, HoyerS, OrntoftTF, et al.. High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy. BMC Cancer, 2014, 14(1): 859

[17] FangY, GuX, LiZ, et al.. miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression. Oncol Rep, 2013, 30(1): 399-406

[18] SchmittgenTD, LivakKJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 2008, 3(1): 1101-1108

[19] KentOA, MendellJT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene, 2006, 25(46): 6188-6196

[20] VermaV, LautenschlaegerT. MicroRNAs in nonsmall cell lung cancer invasion and metastasis: from the perspective of the radiation oncologist. Expert Rev Anticancer Ther, 2016, 16(7): 767-774

[21] ZhangY, XuX, ZhangM, et al.. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD. BMC Cancer, 2016, 16(1): 315

[22] YangYR, LiYX, GaoXY, et al.. MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells. Int J Clin Exp Pathol, 2015, 8(1): 10 847-10 853

[23] LiuF, WangX, LiJ, et al.. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer. Cell Prolif, 2015, 48(5): 582-592

[24] RenP, GongF, ZhangY, et al.. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN. Tumour Biol, 2016, 37(3): 3215-3225

[25] YanA, YangC, ChenZ, et al.. MiR-761 promotes progression and metastasis of non-small cell lung cancer by targeting ING4 and TIMP2. Cell Physiol Biochetn, 2015, 37(1): 55-66

[26] HsuSY, LiangSG, HsuehAJ. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol, 1998, 12(12): 1830-1845

[27] LohED, BroussardSR, LiuQ, et al.. Chromosomal localization of GPR48, a novel glycoprotein hormone receptor like GPCR, in human and mouse with radiation hybrid and interspecific backcross mapping. Cytogenet Cell Genet, 2000, 89(1–2): 2-5

[28] GaoY, KitagawaK, HiramatsuY, et al.. Up-regulation of GPR48 induced by down-regulation of p27Kipl enhances carcinoma cell invasiveness and metastasis. Cancer Res, 2006, 66(24): 11 623-11 631

[29] GongX, YiJ, CarmonKS, et al.. Aberrant RSP03-LGR4 signaling in Keapl-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene, 2015, 34(36): 4692-4701

[30] DongY, ZhengY, XiaoJ, et al.. MicroRNA let-7b induces lens epithelial cell apoptosis by targeting leucine-rich repeat containing G protein-coupled receptor 4 (Lgr4) in age-related cataract. Exp Eye Res, 2016, 147(1): 98-104